{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:43:58Z","timestamp":1783651438247,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.jad.2006.02.009","type":"journal-article","created":{"date-parts":[[2006,3,16]],"date-time":"2006-03-16T12:16:49Z","timestamp":1142511409000},"page":"277-281","source":"Crossref","is-referenced-by-count":17,"title":["Influence of the catechol-O-methyltransferase Val108\/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder\u2014A preliminary report"],"prefix":"10.1016","volume":"92","author":[{"given":"Ricardo","family":"D\u00e1vila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Zum\u00e1rraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Basterreche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Arr\u00fae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Isabel","family":"Zamalloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan B.","family":"Anguiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2006.02.009_bib1","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1523\/JNEUROSCI.23-06-02008.2003","article-title":"Catechol-O-methyltransferase genotype and dopamine regulation in the human brain","volume":"15","author":"Akil","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jad.2006.02.009_bib2","series-title":"The Scale for the Assessment of Positive Symptoms (SAPS)","author":"Andreasen","year":"1984"},{"key":"10.1016\/j.jad.2006.02.009_bib3","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/sj.npp.1300542","article-title":"The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes","volume":"29","author":"Bilder","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2006.02.009_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00004714-198704000-00005","article-title":"Early neuroleptic response: clinical profiles and plasma catecholamine metabolites","volume":"7","author":"Bowers","year":"1987","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2006.02.009_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0025-7753(02)73419-2","article-title":"Versi\u00f3n espa\u00f1ola de la escala de evaluaci\u00f3n de la man\u00eda: validez y fiabilidad de la escala de Young","volume":"119","author":"Colom","year":"2002","journal-title":"Med. Clin. (Barc)"},{"key":"10.1016\/j.jad.2006.02.009_bib6","first-page":"307","article-title":"A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls","volume":"20","author":"Davidson","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2006.02.009_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-3223(89)90141-8","article-title":"Plasma HVA, neuroleptics, and dopaminergic plasticity","volume":"25","author":"D\u00e1vila","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2006.02.009_bib8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archpsyc.1988.01800300060007","article-title":"Plasma homovanillic acid is a predictor of response to neuroleptics","volume":"45","author":"D\u00e1vila","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2006.02.009_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-3223(95)00245-C","article-title":"Plasma prolactine and plasma homovanillic acid predictors of clinical response in schizophrenia","volume":"38","author":"D\u00e1vila","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2006.02.009_bib10","series-title":"Homovanillic Acid in Schizophrenia","first-page":"89","article-title":"Early increase of plasma HVA during neuroleptic treatment: a tool for outcome prediction and subtyping of schizophrenia","author":"D\u00e1vila","year":"1997"},{"key":"10.1016\/j.jad.2006.02.009_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0920-9964(93)90074-S","article-title":"Haloperidol response and plasma catecholamines and their metabolites","volume":"10","author":"Green","year":"1993","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2006.02.009_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1176\/ajp.154.1.113","article-title":"Association analysis of the catechol-O-methyltransferase gene and bipolar affective disorder","volume":"154","author":"Gutierrez","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2006.02.009_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0006-3223(96)00366-6","article-title":"No evidence for an association of affective disorders with high- or low-activity allele of catechol-O-methyltransferase gene","volume":"42","author":"Kunugi","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2006.02.009_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-0327(97)00159-6","article-title":"Pretreatment plasma HVA predicts neuroleptic response in manic psychosis","volume":"48","author":"Mazure","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2006.02.009_bib15","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptor: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2006.02.009_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0006-3223(99)00098-0","article-title":"Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles","volume":"46","author":"Palmatier","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2006.02.009_bib17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archpsyc.1986.01800070059008","article-title":"Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients: correlation with psychosis and response to clinical treatment","volume":"43","author":"Pickar","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2006.02.009_bib18","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/clinchem\/33.6.844","article-title":"Determination of free MHPG in plasma and CSF by HPLC","volume":"33","author":"Rizzo","year":"1987","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jad.2006.02.009_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1176\/appi.ajp.159.1.23","article-title":"Catechol-O-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder","volume":"159","author":"Rotondo","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2006.02.009_bib20","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1073\/pnas.0409766102","article-title":"Dopamine supersensitivity correlates with D2 high states, implying many paths to psychosis","volume":"102","author":"Seeman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jad.2006.02.009_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ajmg.10357","article-title":"Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO A, and G\u03b23 variants","volume":"114","author":"Serretti","year":"2002","journal-title":"Am. J. Med. Genet. (Neuropsychiatric Genetics)"},{"key":"10.1016\/j.jad.2006.02.009_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the clinical global impression (CGI) scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2006.02.009_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00213-004-1924-5","article-title":"Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia","volume":"177","author":"Sumiyoshi","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2006.02.009_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0920-9964(01)00364-4","article-title":"An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention","volume":"54","author":"Tsuang","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2006.02.009_bib25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0006-3223(01)01252-5","article-title":"Prefrontal neurons and the genetics of schizophrenia","volume":"50","author":"Weinberger","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2006.02.009_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.pharmtox.39.1.19","article-title":"Methylation pharmacogenetics: catechol-O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase","volume":"39","author":"Weinshilboum","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jad.2006.02.009_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-3223(94)91201-7","article-title":"Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder","volume":"35","author":"Young","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2006.02.009_bib28","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/clinchem\/40.11.2119","article-title":"Homovanillic acid in plasma determined by HPLC with direct injection of plasma filtrates","volume":"40","author":"Zum\u00e1rraga","year":"1994","journal-title":"Clin. Chem."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032706000863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032706000863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T07:03:04Z","timestamp":1586761384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032706000863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":28,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0165032706000863"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2006.02.009","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}